Adverse events of monoclonal antibodies use in therapy of hematological malignancies.
- Published in:
- Hematology in Clinical Practice, 2021, v. 33, n. 3/4, p. 121, doi. 10.5603/HCP.2021.0014
- By:
- Publication type:
- Article
Works matching IS 27201015 AND DT 2021 AND VI 33 AND IP 3/4
Results: 3
1
2
Acute promyelocytic leukemia: from genetic lesions identification to molecularly targeted therapy.
- Published in:
- Hematology in Clinical Practice, 2021, v. 33, n. 3/4, p. 105, doi. 10.5603/HCP.a2021.0009
- By:
- Publication type:
- Article
3
JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms.
- Published in:
- Hematology in Clinical Practice, 2021, v. 33, n. 3/4, p. 89, doi. 10.5603/HCP.a2021.0013
- By:
- Publication type:
- Article